NGM Biopharmaceuticals, Inc. Net Income 2019-2023 | NGM
NGM Biopharmaceuticals, Inc. net income from 2019 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| NGM Biopharmaceuticals, Inc. Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $-142 |
| 2022 | $-163 |
| 2021 | $-120 |
| 2020 | $-102 |
| 2019 | $-43 |
| 2018 | $-0 |
| 2017 | $-14 |
| NGM Biopharmaceuticals, Inc. Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2023-12-31 | $-28 |
| 2023-09-30 | $-29 |
| 2023-06-30 | $-38 |
| 2023-03-31 | $-48 |
| 2022-12-31 | $-36 |
| 2022-09-30 | $-47 |
| 2022-06-30 | $-47 |
| 2022-03-31 | $-32 |
| 2021-12-31 | $-27 |
| 2021-09-30 | $-29 |
| 2021-06-30 | $-37 |
| 2021-03-31 | $-28 |
| 2020-12-31 | $-28 |
| 2020-09-30 | $-30 |
| 2020-06-30 | $-26 |
| 2020-03-31 | $-19 |
| 2019-12-31 | $-16 |
| 2019-09-30 | $-11 |
| 2019-06-30 | $-8 |
| 2019-03-31 | $-8 |
| 2018-12-31 | $14 |
| 2018-09-30 | $-8 |
| 2018-06-30 | $-3 |
| 2018-03-31 | $-4 |
